Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 ビュー
• 08/04/23
0
0
埋め込む
administrator
加入者
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント